1. 1316PImpact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study. (23rd October 2018) Authors: Strosberg, J; Hendifar, A; Yao, J C; Kulke, M; O'Dorisio, T; Caplin, M; Baum, R P; Kunz, P; Hobday, T; Wolin, E; Mittra, E S; Oberg, K; Ruszniewski, P; Polack, B; He, B; Barton, D; Santaro, P; Krenning, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 482PRET rearrangements may arise following anti-EGFR therapy in advanced colorectal cancer. (23rd October 2018) Authors: Rich, T A; Clifton, K; Grothey, A; Hendifar, A; Henry, D H; Kagawa, Y; Nakamura, Y; Okamoto, W; Tan, B R; Sherrill, G; Yoshino, T; Raymond, V M; Shiotsu, Y; Lanman, R B; Morris, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 741PHealth-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature review (SLR). (23rd October 2018) Authors: Macarulla Mercade, T; Hendifar, A; Li, C-P; Reni, M; Riess, H; Tempero, M A; Dueck, A; Botteman, M F; Deshpande, C; Lucas, E; Oh, D-Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA). (23rd October 2018) Authors: Van Cutsem, E; Corrie, P G; Ducreux, M P; Sigal, D; Sahai, V; Oh, D-Y; Bullock, A; Bang, Y-J; Baron, A D; Hendifar, A; Li, C-P; Philip, P; Reni, M; Zalupski, M; Zheng, L; Berman, C; Chondros, D; Tempero, M A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. (2nd July 2019) Authors: Tempero, M; Oh, D; Macarulla, T; Reni, M; Cutsem, E Van; Hendifar, A; Waldschmidt, D; Starling, N; Bachet, J; Chang, H; Maurel, J; Lonardi, S; Coussens, L; Fong, L; Tsao, L; Cole, G; James, D; Tabernero, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗